PatternsRadar
Sign in

BALPHARMABal Pharma Limited

NSEESM 1Band 5%
83.21INR-1.40 (-1.65%)Close · 20 Nov 2026
11 Nov 2026Last results
—Sector
—Industry
₹132 CrMarket cap
16.7P/E (TTM)
100.0%Delivery

Filings & corporate actions

91 results filed
CSV
Next results · Q3 FY27
Expected 7 Feb 2027 – 14 Feb 2027
Estimate: filed 38–45 days after quarter end, last 5 times
Dividend
₹1.20 per share · last 17 Sept 2026
2026
  • 11 NovresultsResults · Q2 FY27 · consolidated and standalone+5.0%NSE
  • 13 OctshareholdingShareholding · 30 Sept 2026+1.7%NSE
  • 17 SeptdividendDividend · ₹1.20 per share · record 17 Sept 2026+1.1%
  • 12 AugresultsResults · Q1 FY27 · consolidated and standalone-2.5%NSE
  • 22 JulresultsResults · Q4 FY26 · consolidated and standalone+0.8%NSE
  • 13 JulshareholdingShareholding · 30 Jun 2026-0.3%NSE
  • 27 MayresultsResults · Q4 FY26 · consolidated and standalone-6.5%NSE
  • 8 AprshareholdingShareholding · 31 Mar 2026+5.7%NSE
  • 11 FebresultsResults · Q3 FY26 · consolidated and standalone+4.7%NSE
  • 13 JanshareholdingShareholding · 31 Dec 2025-1.2%NSE

Reaction to results · all yearsrose on day 0 in 27 of 80 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2711 Nov 2026+5.0%+0.8%—1.9×
Q1 FY2712 Aug 2026-2.5%-4.2%+17.4%0.6×
Q4 FY2627 May 2026-6.5%-10.6%-17.7%1.7×
Q3 FY2611 Feb 2026+4.7%+8.7%-3.5%2.6×
Q2 FY2612 Nov 2025-2.1%-4.7%-10.6%1.8×
Q1 FY2611 Aug 2025-2.1%-6.0%-4.5%1.3×
Q4 FY2529 May 2025-2.5%+0.7%+0.2%2.2×
Q3 FY2514 Feb 2025-4.5%-4.0%-18.1%3.2×
Q2 FY2515 Nov 2024+5.0%+9.3%+2.0%5.3×
Q1 FY2513 Aug 2024-9.0%-4.0%+9.2%4.8×
Q4 FY2429 May 2024+0.7%-6.8%-2.3%21.8×
Q3 FY2413 Feb 2024-5.3%+0.7%-15.4%0.5×
Q2 FY249 Nov 2023+0.9%+21.4%+13.6%1.4×
Q1 FY2411 Aug 2023-1.1%-0.8%-0.8%0.4×
Q4 FY2330 May 2023-0.4%+7.5%+12.5%0.5×
Q3 FY237 Feb 2023+0.4%-6.6%-9.4%0.7×
Q2 FY2315 Nov 2022-1.4%-4.8%-3.7%0.9×
Q1 FY2312 Aug 2022-2.3%-3.7%+2.2%0.5×
Q4 FY2231 May 2022-0.7%-0.2%-1.3%1.2×
Q3 FY2211 Feb 2022-4.3%-9.9%-8.4%0.3×
Q2 FY2211 Nov 2021-1.9%-5.6%+2.6%1.2×
Q1 FY2211 Aug 2021+1.9%+2.4%+6.4%1.6×
Q4 FY2130 Jun 2021-1.7%-5.6%-7.5%1.1×
Q3 FY2112 Feb 2021-3.5%-9.5%+2.5%3.5×
Q2 FY2112 Nov 2020-2.0%-4.8%+1.5%0.2×
Q1 FY219 Sept 2020+0.8%+5.7%+24.3%1.2×
Q4 FY2030 Jul 2020+4.4%+5.8%+12.5%3.4×
Q3 FY2012 Feb 2020-4.2%-13.4%-36.6%0.6×
Q2 FY2015 Nov 2019-4.0%-10.4%-11.9%0.5×
Q1 FY2014 Aug 2019-6.5%-26.9%-4.0%0.6×
Q4 FY1926 Jun 2019+0.5%+3.1%-14.9%1.8×
Q3 FY1926 Feb 2019-3.6%-0.6%-4.9%4.0×
Q2 FY1926 Nov 2018-0.9%-0.2%-0.6%0.3×
Q1 FY1923 Aug 2018-2.3%-1.5%-0.1%1.2×
Q4 FY186 Jul 2018-0.2%-0.3%+1.4%0.2×
Q3 FY1813 Mar 20180.0%-5.1%-6.1%0.5×
Q2 FY1813 Dec 2017-2.1%-2.2%+16.9%0.7×
Q1 FY1822 Sept 2017-3.6%-3.1%-2.4%0.8×
Q4 FY1715 Jun 2017+2.1%+16.5%+8.6%0.7×
Q3 FY179 Feb 2017-0.6%-4.3%-4.5%0.8×
Q2 FY1718 Nov 2016-0.3%-1.2%+1.1%0.8×
Q1 FY1712 Aug 2016-1.7%-1.1%+6.6%0.2×
Q4 FY1629 May 2016+2.2%-0.3%-0.2%1.6×
Q3 FY1613 Feb 2016+1.1%-2.4%+24.6%1.2×
Q2 FY1610 Nov 2015+3.4%-2.9%+53.1%0.3×
Q1 FY1614 Aug 2015-2.0%-9.4%+0.6%0.6×
Q4 FY1529 May 2015-4.3%-18.6%-18.3%1.5×
Q3 FY1519 Feb 2015+0.3%-4.7%+1.1%0.6×
Q2 FY1513 Nov 2014-1.3%-7.6%-9.0%0.2×
Q1 FY1518 Aug 2014-0.9%-2.6%+6.7%0.3×
Q4 FY143 Jul 2014+5.0%+4.4%+17.4%0.3×
Q3 FY1418 Feb 2014+4.9%+28.9%+24.1%3.3×
Q2 FY1421 Nov 20130.0%+2.3%+9.1%0.6×
Q1 FY1414 Aug 2013+1.3%+8.8%0.0%1.2×
Q4 FY1327 Jun 2013+18.7%+18.7%+21.4%0.9×
Q3 FY1320 Feb 2013-1.2%-1.2%-5.9%0.3×
Q2 FY1312 Nov 2012-0.2%+5.7%+17.8%0.4×
Q1 FY1321 Aug 2012-1.3%-3.1%+17.3%0.4×
Q4 FY1211 May 2012-2.0%-5.3%-7.3%0.6×
Q3 FY126 Feb 2012-5.0%-5.2%-14.4%1.6×
Q2 FY128 Nov 2011+1.4%-16.7%-14.0%2.4×
Q1 FY1223 Aug 2011-0.9%+0.2%-0.2%1.0×
Q4 FY1113 May 2011+10.1%+12.1%+13.3%6.2×
Q3 FY1131 Jan 2011-1.8%-4.2%-8.1%0.0×
Q2 FY1113 Nov 2010-3.6%-15.8%-22.0%0.3×
Q1 FY119 Aug 2010-0.7%-5.4%-2.5%0.2×
Q4 FY1014 May 2010-2.0%-0.7%-4.1%0.4×
Q3 FY1027 Jan 2010+0.2%-5.4%-7.4%0.5×
Q2 FY1031 Oct 2009-3.9%+4.1%+7.1%0.9×
Q1 FY1027 Jul 2009+2.1%+0.7%+14.3%1.3×
Q4 FY0929 Jun 2009+2.4%-7.4%-6.6%0.7×
Q3 FY0931 Jan 2009-1.0%+1.9%-12.5%0.0×
Q2 FY0927 Oct 2008+18.2%+14.2%+0.3%0.0×
Q1 FY0930 Jul 2008-2.1%+7.5%+4.3%1.1×
Q4 FY0824 Jun 2008-6.3%-14.6%-12.8%1.0×
Q3 FY0824 Jan 2008-1.8%-1.8%-2.8%0.2×
Q2 FY0831 Oct 2007-0.7%+3.3%+20.1%3.7×
Q1 FY0830 Jul 2007+2.3%+5.2%+0.6%0.4×
Q4 FY071 Jul 2007+0.2%-4.6%-11.5%1.0×
Q3 FY073 Feb 2007-2.8%-8.1%-22.4%0.1×
Average-0.4%-1.4%+0.3%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+21.5%
Profit YoY+99.9%
Interest cost YoY+8.8%
Revenue QoQ+1.5%
Profit QoQ+26.3%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+3.9%+2.9%+5.0%—+10.4%—
Profit+1.6%+34.9%+27.2%———

Key data

Open86.43
Day range82.15 – 86.43
52-week range60.00 – 124.60
From 52w high-33.2%
RSI (14)42.6
ATR (14)4.11
Volume5.5K
Avg volume (20D)9.6K
Rel volume0.57×
Volatility (1Y)47.8%
Turnover₹4.6L
Traded value (NSE)₹4.6L
VWAP83.53
SMA 50 / 20094.42 / 83.69
Price band5%

Delivery percentage

Latest · 20 Nov 2026100.0%
20-day avg100.0%
1-year avg67.6%
Percentile (own history)100th
Range6.5–100.0%
Sessions3,560

Over the last 20 sessions BALPHARMA settled 100.0% of its traded quantity, which is unusually high for an NSE equity. Its one-year average is 67.6%, so recent sessions are running 32.4 points higher than usual. That is the highest reading in the 3,560 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield1.44%
Dividend, trailing 12M₹1.20
Paid every year for6 yr
Shareholders15.2K · +1.8% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy122 days ago

Performance returns

1D1W1M3M6M1Y
Price-1.65%-8.50%-1.61%-3.98%-2.26%+3.50%

Valuation

Market cap₹132 Cr
Market cap (NSE)₹132 Cr
Free-float cap₹65 Cr
P/E (TTM)16.7
P/E (NSE)16.9
EPS (TTM)4.97
P/B1.5
Net margin (TTM)2.3%
Other income / PBT26.7%
ROE9.6%
Debt / equity2.07
Shares outstanding1.59Cr
Listed—

Ownership

Promoter50.86%
Promoter Δ QoQ0.00 pp
Public49.14%
FII0.28%
DII0.00%
Pledged0.00%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)87.784.188.689.9
YoY chg+19.9%+2.7%+34.5%+21.5%
Net profit (₹ Cr)1.83.61.11.4
YoY chg+245.7%-33.0%+445.7%+99.8%
Net margin2.0%4.3%1.3%1.6%
EPS1.122.260.710.89

Shareholding over time

By quarter

30 Sept 2026 · promoter 50.86% · public 49.14%
30 Sept 2021: promoter 46.87%31 Dec 2021: promoter 49.57%31 Mar 2022: promoter 49.57%13 Apr 2022: promoter 52.00%30 Jun 2022: promoter 52.00%30 Sept 2022: promoter 52.00%31 Dec 2022: promoter 51.61%31 Mar 2023: promoter 51.61%30 Jun 2023: promoter 51.61%30 Sept 2023: promoter 51.61%31 Dec 2023: promoter 51.23%31 Mar 2024: promoter 51.23%30 Jun 2024: promoter 51.23%30 Sept 2024: promoter 50.86%31 Dec 2024: promoter 50.86%31 Mar 2025: promoter 50.86%30 Jun 2025: promoter 50.86%30 Sept 2025: promoter 50.86%31 Dec 2025: promoter 50.86%31 Mar 2026: promoter 50.86%30 Jun 2026: promoter 50.86%30 Sept 2026: promoter 50.86%
2021-092026-09
  • Promoter
  • Public and others
Promoter
50.86%
Public
49.14%
Promoter change
0.00 pp
Filed
13 Oct 2026
FII
0.28%
DII
0.00%
Promoter pledged
0.00%

Who the public is

Mutual funds
0.00%

0.00 pp QoQ

Insurance
0.00%

0.00 pp QoQ

FPI
0.28%

+0.13 pp QoQ

Retail ≤ ₹2L
23.39%

+0.42 pp QoQ

HNI > ₹2L
10.09%

+0.20 pp QoQ

NRI
11.30%

-0.53 pp QoQ

Bodies corporate
0.61%

+0.06 pp QoQ

Shareholders
15,241

+1.8% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
SHAILESH SIROYAPromoter · Individual17.24%
Micro Labs LimitedPromoter · Corporate12.64%
ANITA SIROYAPromoter · Individual6.59%
Ram Keshav MurthyIndividual3.31%
ANAND SURANAPromoter · Individual3.30%
CHANDRAPRAKASH DHEERAJMAL SIROYAPromoter · Individual3.06%
DILIP SURANAPromoter · Individual2.98%
Prakash Chandra JainIndividual2.89%
Naresh D PIndividual1.88%
Shreya MardiaIndividual1.88%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 12 Sept 2013 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹1.20₹1.20
FY2025-261₹1.20₹1.20
FY2024-251₹1.20₹1.20
FY2023-241₹1.00₹1.00
FY2022-231₹1.00₹1.00
FY2021-221₹1.00₹1.00
FY2019-201₹1.00₹1.00
FY2018-191₹1.00₹1.00
FY2017-181₹1.00₹1.00
FY2016-171₹1.00₹1.00
FY2015-161₹1.00₹1.00
FY2014-151₹1.00₹1.00
FY2013-141₹0.75₹0.75
Ex-dateRecord dateDeclaredAdjusted
17 Sept 202617 Sept 2026₹1.20₹1.20
18 Sept 2025—₹1.20₹1.20
17 Sept 2024—₹1.20₹1.20
18 Sept 2023—₹1.00₹1.00
13 Sept 2022—₹1.00₹1.00
16 Sept 2021—₹1.00₹1.00
17 Sept 2019—₹1.00₹1.00
14 Sept 2018—₹1.00₹1.00
14 Sept 2017—₹1.00₹1.00
15 Sept 2016—₹1.00₹1.00
15 Sept 2015—₹1.00₹1.00
12 Sept 2014—₹1.00₹1.00
12 Sept 2013—₹0.75₹0.75

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Price-band hits

Loading…

Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.

Book closures & record dates

Loading…

NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
5.2 years ago
Disclosures on record
26
7 open-market of the newest 26
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
24 Nov 2021MICRO LABS LIMITEDOtherBuy4.00L₹3.7Cr92.4516.12L → 20.12L13.57%+2.70 pp7(2)told 24 Nov 2021
27 Aug 2021MICRO LABS LIMITEDPromoterBuy3.01L~₹2.8Cr93.3013.11L → 16.12L10.87%+2.03 pp7(2)told 27 Aug 2021
26 Jun 2017ANITA SIROYAPromoterBuy13.4K₹13.7L102.0510.26L → 10.39L7.33%+0.09 pp7(2)told 23 Jun 2017
26 Jun 2017ANITA SIROYAPromoterBuy10.0K₹10.3L103.1110.39L → 10.49L7.40%+0.07 pp7(2)told 26 Jun 2017
23 Jun 2017ANITA SIROYAPromoterBuy3.4K₹3.5L100.9510.26L → 10.29L7.33%+0.02 pp7(2)told 23 Jun 2017
23 Jun 2017ANITA SIROYAPromoterBuy10.0K₹10.2L102.4210.26L → 10.36L7.30%+0.07 pp7(2)told 23 Jun 2017
20 Apr 2017ANITA SIROYAPromoterBuy7.3K₹6.6L90.4310.19L → 10.26L7.23%+0.05 pp7(2)told 20 Apr 2017

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Bulk & block deals · 21 Jul 2026

CSV
12 of 206 deals
By year
DateDealClientQuantityPriceValue
21 Jul 2026Sell · bulkORION STOCKS LTD1.23L89.70₹1.1Cr
21 Jul 2026Buy · bulkORION STOCKS LTD16.3K89.69₹14.6L
4 Apr 2025Sell · bulkNK SECURITIES RESEARCH PRIVATE LIMITED1.32L121.17₹1.6Cr
4 Apr 2025Buy · bulkNK SECURITIES RESEARCH PRIVATE LIMITED1.32L121.03₹1.6Cr
4 Apr 2025Sell · bulkMUDUPULAVEMULA SURENDRANADHA REDDY1.23L121.51₹1.5Cr
4 Apr 2025Buy · bulkMUDUPULAVEMULA SURENDRANADHA REDDY1.23L120.96₹1.5Cr
4 Apr 2025Buy · bulkPARTH INFIN BROKERS PVT LTD1.11L125.31₹1.4Cr
4 Apr 2025Sell · bulkPARTH INFIN BROKERS PVT LTD1.11L124.36₹1.4Cr
23 Aug 2024Sell · bulkNK SECURITIES RESEARCH PRIVATE LIMITED86.8K143.07₹1.2Cr
23 Aug 2024Buy · bulkNK SECURITIES RESEARCH PRIVATE LIMITED86.8K142.85₹1.2Cr
22 Aug 2024Sell · bulkNK SECURITIES RESEARCH PRIVATE LIMITED90.3K134.93₹1.2Cr
22 Aug 2024Buy · bulkNK SECURITIES RESEARCH PRIVATE LIMITED90.3K134.74₹1.2Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.

Exchange surveillance

20 Nov 2026
  • Under 100 traders in 30 days · since 2 Nov 2026 — Fewer than 100 distinct investors traded it in the last 30 days.
  • ESM · stage 1 · since 1 Oct 2026 — Enhanced Surveillance Measure, for companies under ₹500 crore: a 5% or 2% price band and trade-for-trade settlement.

Price band: 5% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations81.794.674.473.773.281.965.974.087.784.188.689.9
Other income0.12.50.8(0.2)0.51.10.71.10.3(0.2)0.41.6
Total income81.897.175.273.573.783.066.675.188.083.889.191.6
Total expenses80.591.374.672.173.180.466.474.486.280.687.989.6
└ Finance costs3.74.14.23.75.03.94.13.94.94.14.55.0
└ Depreciation3.02.22.42.52.72.22.52.33.23.12.83.4
Profit before tax1.35.80.61.40.62.60.20.71.83.21.11.9
Tax expense0.40.20.40.30.0(2.8)0.00.00.0(0.4)0.00.5
Net profit0.85.50.31.00.55.40.20.71.83.61.11.4
EPS0.543.730.160.650.333.400.130.451.122.260.710.89
Net margin1.04%5.85%0.35%1.41%0.71%6.57%0.32%0.97%2.04%4.29%1.28%1.59%
PBT margin1.55%6.08%0.83%1.85%0.77%3.17%0.32%0.97%2.04%3.83%1.28%2.15%
Tax rate32.93%3.81%57.98%23.47%8.55%-108.93%0.00%0.00%0.00%-12.01%0.00%25.87%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 11 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets313.2329.8320.4339.5335.7349.4375.5408.7
Current assets228.2244.3235.0248.2234.9245.0262.2293.6
└ Cash & equivalents1.51.44.21.91.81.62.35.2
└ Other bank balances6.17.09.111.86.37.11.25.2
└ Current investments0.00.06.811.02.50.42.13.0
└ Trade receivables94.0102.999.6103.292.490.893.6108.2
└ Inventories98.0105.787.889.9103.0112.7116.4122.6
Total equity63.763.269.368.877.478.382.386.9
└ Attributable to owners63.863.369.368.877.478.382.286.9
└ Non-controlling interest(0.1)(0.1)(0.0)(0.0)(0.0)0.00.00.1
└ Share capital15.715.715.815.915.915.915.915.9
Borrowings131.0141.1139.6155.0150.4154.9159.5179.6
└ Current100.5113.0103.3116.0119.0123.5127.6134.5
└ Non-current30.528.136.438.931.431.431.945.1
Trade payables78.997.378.378.381.784.289.0101.3
Current liabilities209.3249.5203.9220.7219.5228.9249.2262.1
Total liabilities249.5266.6251.1270.7258.3271.0293.3321.8
Net debt123.4132.7119.6130.2139.9145.8154.0166.2
Debt / equity2.062.232.022.251.941.981.942.07
Current ratio1.090.981.151.121.071.071.051.12

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow23.07.2329.213.520.73.930.8(1.0)
└ Capex0.00.00.00.00.00.0(18.6)(7.0)
Free cash flow23.07.2329.213.520.73.912.3(8.0)
Investing cash flow18.40.00.012.7(18.1)(20.6)(20.7)(8.8)
Financing cash flow0.00.034.60.00.3(0.9)(9.6)12.7
└ Dividends paid0.00.00.00.00.00.0(1.9)0.0
└ Buybacks0.00.0(1.6)0.00.00.00.00.0
Net change in cash41.57.2363.826.32.9(17.5)0.52.9

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

BALPHARMA at a glance

  • BALPHARMA closed at ₹83.21 on 20 Nov 2026, -1.65% on the day, +3.5% over one year, 33.2% below its 52-week high of ₹124.6.
  • Delivery was 100.0% of traded quantity on 20 Nov 2026, the 100th percentile of its own 3,560 sessions with a reading (20-session average 100.0%, 1-year average 67.6%).
  • Market capitalisation is ₹132 crore at a trailing P/E of 16.7 (trailing EPS ₹4.97).
  • Q2 FY27 results (consolidated, filed 11 Nov 2026): revenue ₹90 crore (+21.5% year on year), net profit ₹1 crore (+99.8%); the price moved +5.0% on the first session after.
  • Promoters held 50.86% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 7 Feb 2027 and 14 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sector—
Basic industry—
ISININE083D01012
SeriesBE
Listed—
NSE market cap · 17 Nov 2026—
Free-float market cap (NSE)—
Shares outstanding (NSE)—
History from8 May 2006
Sessions5,009

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.